company background image
D9Z logo

Clínica Baviera DB:D9Z Stock Report

Last Price

€28.00

Market Cap

€450.0m

7D

-1.4%

1Y

49.7%

Updated

19 Mar, 2024

Data

Company Financials

D9Z Stock Overview

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics.

D9Z fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance5/6
Financial Health6/6
Dividends4/6

Clínica Baviera, S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Clínica Baviera
Historical stock prices
Current Share Price€28.00
52 Week High€29.00
52 Week Low€17.20
Beta0.62
1 Month Change16.67%
3 Month Change19.66%
1 Year Change49.73%
3 Year Change108.96%
5 Year Change132.37%
Change since IPO21.48%

Recent News & Updates

Recent updates

Shareholder Returns

D9ZDE HealthcareDE Market
7D-1.4%-0.6%-0.4%
1Y49.7%1.8%5.0%

Return vs Industry: D9Z exceeded the German Healthcare industry which returned 2.2% over the past year.

Return vs Market: D9Z exceeded the German Market which returned 6.2% over the past year.

Price Volatility

Is D9Z's price volatile compared to industry and market?
D9Z volatility
D9Z Average Weekly Movement4.4%
Healthcare Industry Average Movement5.2%
Market Average Movement4.8%
10% most volatile stocks in DE Market10.3%
10% least volatile stocks in DE Market2.5%

Stable Share Price: D9Z has not had significant price volatility in the past 3 months.

Volatility Over Time: D9Z's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a1,466Eduardo Baviera Sabaterhttps://www.clinicabaviera.com

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, and vías lagrimales treatments.

Clínica Baviera, S.A. Fundamentals Summary

How do Clínica Baviera's earnings and revenue compare to its market cap?
D9Z fundamental statistics
Market cap€449.97m
Earnings (TTM)€36.73m
Revenue (TTM)€224.92m

12.2x

P/E Ratio

2.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
D9Z income statement (TTM)
Revenue€224.92m
Cost of Revenue€157.91m
Gross Profit€67.02m
Other Expenses€30.28m
Earnings€36.73m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.25
Gross Margin29.80%
Net Profit Margin16.33%
Debt/Equity Ratio2.7%

How did D9Z perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

41%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.